[图书][B] Interferon: The science and selling of a miracle drug

T Pieters - 2005 - taylorfrancis.com
This innovative study charts the beginnings, history and fate of Interferon-one of modern
medicine's most famous and infamous drugs. Interferon is part of the medical profession's …

UBR7 E3 Ligase Suppresses Interferon-β Mediated Immune Signaling by Targeting Sp110 in Hepatitis B Virus-Induced Hepatocellular Carcinoma

V Singh, A Mondal, S Adhikary, P Mondal… - ACS Infectious …, 2024 - ACS Publications
A newly discovered E3 ubiquitin ligase, UBR7, plays a crucial role in histone H2BK120
monoubiquitination. Here, we report a novel function of UBR7 in promoting hepatitis B virus …

Human fibroblast interferon for clinical trials: pharmacokinetics and tolerability in experimental animals and humans

A Billiau, P De Somer, VG Edy… - Antimicrobial Agents …, 1979 - Am Soc Microbiol
Human fibroblast interferon (F-interferon) purified by adsorption on controlled-pore glass
was given intramuscularly to patients at daily dosages of up to 20× 106 units. Serum levels …

Chemotherapy of infection.

WB Pratt - 1977 - cabidigitallibrary.org
In 1929 GM Findlay published a moderate sized book entitled" Recent Advances in
Chemotherapy". It dealt mainly with trypanosomes, malaria and amoebae with smaller …

[HTML][HTML] Phytochemical and biological studies of Panicum antidotale aerial parts ethanol extract supported by molecular docking study

I Sarwar, M Asif, T Jamshaid, M Saadullah… - Frontiers in …, 2024 - frontiersin.org
Panicum antidotale has traditionally been used as a poultice to alleviate local inflammation
and painful diseases. This study aimed to evaluate the anti-inflammatory, wound-healing …

[HTML][HTML] A genome-wide gain-of-function screen identifies CDKN2C as a HBV host factor

C Eller, L Heydmann, CC Colpitts, H El Saghire… - Nature …, 2020 - nature.com
Chronic HBV infection is a major cause of liver disease and cancer worldwide. Approaches
for cure are lacking, and the knowledge of virus-host interactions is still limited. Here, we …

Double-blind study of leucocyte interferon administration in chronic HBsAg-positive hepatitis

W Weimar, FJP Ten Kate, N Masurel, RA Heijtink… - The Lancet, 1980 - Elsevier
In a double-blind study human leucocyte interferon was given for six weeks to 8 of 16
patients with chronic HBsAg-positive hepatitis. In the first week 12× 10 6 reference units …

Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination

SL Sacks, GH Scullard, RB Pollard… - Antimicrobial Agents …, 1982 - Am Soc Microbiol
In an uncontrolled trial, 29 patients with chronic hepatitis B virus infection were treated with
93 courses of adenine arabinoside at doses ranging from 2.5 to 15 mg/kg per day. Most …

Pilot study of recombinant human α-interferon for chronic type B hepatitis

JS Dooley, GL Davis, M Peters, JG Waggoner… - Gastroenterology, 1986 - Elsevier
Nine patients with chronic type B hepatitis were entered into a preliminary study of
recombinant, human α-interferon therapy. Patients received one to four courses of Interferon …

Human leukocyte interferon in the treatment of varicella in children with cancer: a preliminary controlled trial

AM Arvin, S Feldman, TC Merigan - Antimicrobial Agents and …, 1978 - Am Soc Microbiol
Eighteen patients who developed varicella while being treated for malignancy received
human leukocyte interferon in a randomized double-blind placebo-controlled trial …